At this year’s European Society of Cardiology (ESC) Congress, positive results were presented from Bayer’s FIGARO-DKD Phase III trial of Kerendia (finerenone), providing insight into the drug’s ability to reduce […]
Type 2 Diabetes
Trending topics and news from the Type 2 Diabetes category
Back to news home